SK Bioscience to Speed Ebola Vaccine Development With CEPI Support

SEOUL, Jan. 22 (Korea Bizwire) – SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it will accelerate the development of a Zaire Ebola virus vaccine with funding from the Coalition for Epidemic Preparedness Innovations (CEPI). The announcement follows a funding agreement between CEPI and U.S. pharmaceutical company MSD to support [...]